The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe and effective HIV vaccine. The grants were awarded under the Innovation for HIV Vaccine Discovery (IHVD) initiative, which is expected to receive up to $34.8 million over the next four years.
"Recent discoveries about the basic biology of HIV and how the virus adapts to its host have provided useful information and new opportunities to guide vaccine development," said NIAID Director Anthony S. Fauci, M.D. "These grants are designed to build on that information and stimulate discovery of new ways to design a robust vaccine that prevents acquisition and establishment of latent infection."
The 14 IHVD grant recipient organizations include:
Altravax Inc. (Sunnyvale, Calif.)
Catholic University of America (Washington, D.C.)
Dartmouth College (Hanover, N.H.)
Duke University (Durham, N.C.)
Harvard Medical School (Boston)
Massachusetts General Hospital (Boston)
NYU Langone Medical Center (New York City)
University of California (Irvine)
University of Maryland (Baltimore)
University of Medicine and Dentistry of New Jersey (Newark)
University of Minnesota (Minneapolis)
University of North Carolina (Chapel Hill)
University of Rochester (Rochester, N.Y.)
University of Texas at El Paso
NIAID conducts and supports research- at NIH, throughout the United States, and worldwide- to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov .
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov .
NIH...Turning Discovery Into Health